Surrogate Endpoints | Evidera
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Table I from Surrogate markers in HIV disease. | Semantic Scholar
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework | Nature Reviews Drug Discovery
Surrogate markers of infection: interrogation of the immune system | Biomarkers in Medicine
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - ScienceDirect
Surrogate Endpoints and Biomarkers | Basicmedical Key
Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library
![PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ae9f320037de4f081b4772e3245508f1d8bc6b3/3-Figure1-1.png "PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar")
PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Optimized sensitive and inexpensive method to measure D-lactate as a surrogate marker of methylglyoxal fluxes in metabolically relevant contexts - ScienceDirect
flowCAST-Basophils-Surrogate-Marker - Buhlmann Diagnostics Corp
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | GeroScience
JCM | Free Full-Text | Corneal Hysteresis, Intraocular Pressure, and Progression of Glaucoma: Time for a “Hyst-Oric” Change in Clinical Practice?
Proteomics of Hepatocellular Carcinoma: Serum Vimentin As a Surrogate Marker for Small Tumors (≤2 cm) | Journal of Proteome Research
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
Pharmacodynamic markers and surrogate endpoints are a subset of... | Download Scientific Diagram
